Samsung Biologics
₩1,373,000
▼ 19000.00
(-1.36%)
Volume: 37,490
· 2026-09-23
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
24
- 21d momentum -13.4%
- MA aligned bearish
- RSI 34
🎯
Pullback
62
- RSI 34 near lows
- Near lower Bollinger band
- -5.1% vs 20MA
💎
Value
78
- ROE 5.9%
- Op. margin 46.2%
- -31% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)34.1
MACD-7160
MA trendBearish
ATR2.87%
21d mom.-13.4%
63d mom.-0.9%
vs 20MA-5.1%
RVOL(20)0.93×
52w low · 1,228,000
52w high · 1,987,000
-30.9% from 52-week high
20d support 1,360,000
· resistance 1,611,000
Computed live from daily OHLCV · as of 2026-09-23
🏦 Fundamentals
ROE5.9%
Op. margin46.2%
Net margin37.3%
FY2026
| Year | Revenue | Op. income | Op. margin |
|---|---|---|---|
| 2023 | 3.7T | 1.1T | 30.1% |
| 2024 | 4.5T | 1.3T | 29.0% |
| 2025 | 4.6T | 2.1T | 45.4% |
| 2026 | 1.3T | 0.6T | 46.2% |
From DART financial statements (KRW). Annual (or latest reported quarter).
⚖️ AI Bull vs Bear
14d momentum -7.04%, daily vol 1.67%. Samsung Biologics sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.
🏦 Investor Flow
Foreign
-98억
Institution
-94억
Retail
+189억
| Date | Foreign | Inst. | Retail |
|---|---|---|---|
| 09-23 | -98 | -94 | +189 |
| 09-22 | +32 | -134 | +91 |
| 09-21 | +53 | -59 | +5 |
| 09-18 | -2 | -22 | +23 |
| 09-17 | +22 | -93 | +72 |
Net buy/sell in ₩100M (억). Positive = net buying.